Zephyr AI Secures $111M In Series A To Advance Precision Medicine – Slice of Healthcare
Quoting Slice of Healthcare on LinkedIn:
“Zephyr AI Secures $111M In Series A To Advance Precision Medicine. Learn more and get our take.
“The US has the highest rate of avoidable cancer and cardiometabolic-related deaths among any high-income country. We must do better,” – Grant Verstandig, Co-Founder and Executive Chairman at Zephyr AI.
“Our technology…has empirically demonstrated the ability to navigate the intricacies of real-world patient data,” – Dr. Justin Stebbing, Chairman of the Scientific and Medical Advisory Board at Zephyr AI.
“The expansion of our diverse multimodal data resources will accelerate the advancement of Zephyr AI’s algorithms,” – Jeff Sherman Co-Founder, Interim CEO, and CTO at Zephyr AI.”
Source: Slice of Healthcare/LinkedIn